- Trials with a EudraCT protocol (35)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Patients with seasonal allergic rhinitis, conjunctivitis and possobly asthma symptoms so far only statistical analysis, Publication sheduled. Age of patients: 5 - 79 Years |
| Active substance: 158 Rye |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39753 |
| Study title: Abschlussbericht: Offene kontrollierte Studie zum Vergleich der Wirsamkeit und Verträglichkeit von Solco-Derman und Verrumal bei Hautwarzen, Rozman T, et al., Nov. 7, 1988 |
| Active substance: ACETIC ACID_OXALIC ACID_NITRIC ACID_LACTIC ACID_COPPER (II) NITRATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21256 |
| Study title: Offene kontrollierte Studie zum Vergleich der Wirsamkeit und Verträglichkeit von Solco-Derman und Verrumal bei Hautwarzen, Rozman T, et al., Nov. 7, 1988 |
| Active substance: ACETIC ACID_OXALIC ACID_NITRIC ACID_LACTIC ACID_COPPER (II) NITRATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21250 |
| Study title: Short-time-immunotherapy with Allergoids, results from prospective, open Study in allergergological practices; Allergovit patients with seasonal rhino conjunctivitis and/or asthma symptoms Age of patients: 4 – 75 Years, 2047 Patients Allergologie, Jahrgang 28, Nr. 10/2005, S. 391-400 |
| Active substance: 006 Grasses (178 Kentucky Blue Grass, 179 Meadow Fescue, 140 Orchard Grass, 157 Rye Grass, 177 Timothy Grass, 133 Velvet Grass) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39754 |
| Study title: Ballmer−Weber−B−K, Gex−Collet−C, Wüthrich−B. Inhibition of histamine or allergen−induced wheals by a single dose of acrivastine, fexofenadine or cetirizine. Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Nov−Dec 1999, vol. 9, no. 6, p. 351−5.Ballmer−Weber−B−K, Gex−Collet−C, Wüthrich−B. Inhibition of histamine or allergen−induced wheals by a single dose of acrivastine, fexofenadine or cetirizine. Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Nov−Dec 1999, vol. 9, no. 6, p. 351−5. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46229 |
| Study title: Dockhorn−R−J, Williams−B−O, Sanders−R−L. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Annals of allergy asthma & immunology : official publication of the American College of Allergy Asthma & Immunology, {Ann−Allergy−Asthma− Immunol}, Feb 1996, vol. 76, no. 2, p. 204−8.Dockhorn−R−J, Williams−B−O, Sanders−R−L. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Annals of allergy asthma & immunology : official publication of the American College of Allergy Asthma & Immunology, {Ann−Allergy−Asthma− Immunol}, Feb 1996, vol. 76, no. 2, p. 204−8. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46221 |
| Study title: Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4.Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46224 |
| Study title: Medical report of a double-blind, placebo-controlled, crossover study, to evaluate the efficacy and safety of 3 daily doses of 4 mg BW825C in children (6-13 yrs) exhibiting the symptoms of perennial allergic rhinitis, conducted by Dr. E.G. Weinberg, Cape Town, South Africa. Report No. BRAH/85/0011/00 |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): Study H40-082-C86-Acrivastine.xls |
| View full study record |
| Document reference: 46227 |
| Study title: Meran−A, Morse−J, Gibbs−T−G. A cross−over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology, {Rhinology}, Mar 1990, vol. 28, no. 1, p. 33−40.Meran−A, Morse−J, Gibbs−T−G. A cross−over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology, {Rhinology}, Mar 1990, vol. 28, no. 1, p. 33−40. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46223 |
| Study title: Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142.Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46222 |
| Study title: Dockhorn−R−J, Williams−B−O, Sanders−R−L. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Annals of allergy asthma & immunology : official publication of the American College of Allergy Asthma & Immunology, {Ann−Allergy−Asthma− Immunol}, Feb 1996, vol. 76, no. 2, p. 204−8.Dockhorn−R−J, Williams−B−O, Sanders−R−L. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Annals of allergy asthma & immunology : official publication of the American College of Allergy Asthma & Immunology, {Ann−Allergy−Asthma− Immunol}, Feb 1996, vol. 76, no. 2, p. 204−8. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46230 |
| Study title: Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4.Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46233 |
| Study title: Meran A et al. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology 1990; 28(1): 33-40 Meran A et al. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology 1990; 28(1): 33-40 |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46249 |
| Study title: Meran−A, Morse−J, Gibbs−T−G. A cross−over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology, {Rhinology}, Mar 1990, vol. 28, no. 1, p. 33−40.Meran−A, Morse−J, Gibbs−T−G. A cross−over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology, {Rhinology}, Mar 1990, vol. 28, no. 1, p. 33−40. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46232 |
| Study title: Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142.Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46231 |
| Study title: Williams BO et al. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Ann Allergy Asthma Immunol 1996; 76(5):432-438 Williams BO et al. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Ann Allergy Asthma Immunol 1996; 76(5):432-438 |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25784 |
| Study title: Williams−B−O, Hull−H, McSorley−P, Frosolono−M−F, Sanders−R−L. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 1996, Vol/Iss/Pg. 76/5 (432−438).Williams−B−O, Hull−H, McSorley−P, Frosolono−M−F, Sanders−R−L. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 1996, Vol/Iss/Pg. 76/5 (432−438). |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46235 |
| Study title: Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolff-Parkinson-White syndrome treadted with digoxin - Mulla N et al. - 1995 (Pediatr. Emerg. Care, 11 (4) 238-239)Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolff-Parkinson-White syndrome treadted with digoxin - Mulla N et al. - 1995 (Pediatr. Emerg. Care, 11 (4) 238-239) |
| Active substance: ADENOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46305 |
| Study title: Williams−B−O, Hull−H, McSorley−P, Frosolono−M−F, Sanders−R−L. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 1996, Vol/Iss/Pg. 76/5 (432−438).Williams−B−O, Hull−H, McSorley−P, Frosolono−M−F, Sanders−R−L. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 1996, Vol/Iss/Pg. 76/5 (432−438). |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46226 |
| Study title: A clinical trial to evaluate the efficacy and safety of compound pseudoephedrine hydrochloride sustained release capsule in patients with seasonal allergic rhinitis. Zhonghua Er Bi Yan Hou Ke Za Zhi 2004; 39(9):549-53A clinical trial to evaluate the efficacy and safety of compound pseudoephedrine hydrochloride sustained release capsule in patients with seasonal allergic rhinitis. Zhonghua Er Bi Yan Hou Ke Za Zhi 2004; 39(9):549-53 |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46237 |
